440 related articles for article (PubMed ID: 18566560)
1. Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients.
Hakeam HA; Al-Jedai AH; Raza SM; Hamawi K
Ann Transplant; 2008; 13(2):46-53. PubMed ID: 18566560
[TBL] [Abstract][Full Text] [Related]
2. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
Chhabra D; Skaro AI; Leventhal JR; Dalal P; Shah G; Wang E; Gallon L
Clin J Am Soc Nephrol; 2012 Mar; 7(3):504-12. PubMed ID: 22282478
[TBL] [Abstract][Full Text] [Related]
3. A 12-month single arm pilot study to evaluate the efficacy and safety of sirolimus in combination with tacrolimus in kidney transplant recipients at high immunologic risk.
Lee J; Lee JJ; Kim BS; Lee JG; Huh KH; Park Y; Kim YS
J Korean Med Sci; 2015 Jun; 30(6):682-7. PubMed ID: 26028917
[TBL] [Abstract][Full Text] [Related]
4. Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus.
de Sandes-Freitas TV; Felipe CR; Campos ÉF; de Lima MG; Soares MF; de Franco MF; Aguiar WF; Tedesco-Silva H; Medina-Pestana JO
Transplantation; 2015 Nov; 99(11):2372-81. PubMed ID: 25929604
[TBL] [Abstract][Full Text] [Related]
5. Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen.
Spinelli GA; Felipe CR; Park SI; Mandia-Sampaio EL; Tedesco-Silva H; Medina-Pestana JO
Transplant Proc; 2011 Dec; 43(10):3730-7. PubMed ID: 22172836
[TBL] [Abstract][Full Text] [Related]
6. Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens.
Felix MJ; Felipe CR; Tedesco-Silva H; Osmar Medina-Pestana J
Pharmacotherapy; 2016 Feb; 36(2):152-65. PubMed ID: 26799522
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
8. [Sirolimus use in heart transplantation recipients with chronic renal dysfunction].
Yin D; Huang J; Feng L; Liao ZK; Feng GX; Wang W; Song YH; Hu SS
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Feb; 40(2):136-40. PubMed ID: 22490714
[TBL] [Abstract][Full Text] [Related]
9. Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus.
Trotter JF; Wachs ME; Trouillot TE; Bak T; Kugelmas M; Kam I; Everson G
Liver Transpl; 2001 May; 7(5):401-8. PubMed ID: 11349259
[TBL] [Abstract][Full Text] [Related]
10. Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant.
Rivelli RF; Gonçalves RT; Leite M; Santos MA; Delgado AG; Cardoso LR; Takiya CM
Nephrology (Carlton); 2015 Mar; 20(3):168-76. PubMed ID: 25404086
[TBL] [Abstract][Full Text] [Related]
11. A comparative, randomized trial of concentration-controlled sirolimus combined with reduced-dose tacrolimus or standard-dose tacrolimus in renal allograft recipients.
Bechstein WO; Paczek L; Wramner L; Squifflet JP; Zygmunt AJ;
Transplant Proc; 2013; 45(6):2133-40. PubMed ID: 23953523
[TBL] [Abstract][Full Text] [Related]
12. Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation.
Lo A; Egidi MF; Gaber LW; Shokouh-Amiri MH; Nazakatgoo N; Fisher JS; Gaber AO
Clin Transplant; 2004 Feb; 18(1):53-61. PubMed ID: 15108771
[TBL] [Abstract][Full Text] [Related]
13. Lipid metabolism in renal transplant patients receiving tacrolimus/sirolimus combination therapy.
Wlodarczyk Z; Vitko S; Salmela K; Czajkowski Z; Margreiter R;
Transplant Proc; 2005 May; 37(4):1871-3. PubMed ID: 15919489
[TBL] [Abstract][Full Text] [Related]
14. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ
Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
[TBL] [Abstract][Full Text] [Related]
15. Proteinuria among primarily sirolimus treated live-donor renal transplant recipients' long-term experience.
Hamdy AF; Bakr MA; Ghoneim MA
Exp Clin Transplant; 2010 Dec; 8(4):283-91. PubMed ID: 21143093
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus Associated with Tacrolimus at Low Doses in Elderly Kidney Transplant Patients: A Prospective Randomized Controlled Trial.
Kojima CA; Nga HS; Takase HM; Bravin AM; Martinez Garcia MFF; Garcia PD; Contti MM; de Andrade LGM
Exp Clin Transplant; 2018 Jun; 16(3):301-306. PubMed ID: 28836934
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
[TBL] [Abstract][Full Text] [Related]
18. Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus.
Dean PG; Lund WJ; Larson TS; Prieto M; Nyberg SL; Ishitani MB; Kremers WK; Stegall MD
Transplantation; 2004 May; 77(10):1555-61. PubMed ID: 15239621
[TBL] [Abstract][Full Text] [Related]
19. Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis.
Chueh SC; Kahan BD
Transplantation; 2003 Jul; 76(2):375-82. PubMed ID: 12883196
[TBL] [Abstract][Full Text] [Related]
20. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]